Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

February 4, 2021

CT nets $7.5 million from McKinsey settlement over role in opioid epidemic

Photo | Contributed Purdue Pharma's Stamford headquarters.
By Liese Klein

Connecticut will get $7.5 million as part of a nationwide settlement with McKinsey & Company, accused of accelerating the opioid epidemic with its advice to drug companies, the state attorney general announced Thursday. 

The consulting firm agreed to a $573 million total settlement to resolve probes by Attorney General William Tong and 46 other states into its activities. Connecticut was part of a 10-state executive committee that negotiated the settlement.

McKinsey has also agreed to prepare tens of thousands of its internal documents detailing its work for Purdue Pharma and other opioid companies for public disclosure online.  McKinsey also agreed to adopt a strict document retention plan, implement a strict ethics code and stop advising companies on sales of potentially dangerous Schedule II and III narcotics. 

“McKinsey consultants devised a deadly roadmap for Purdue to turbocharge the opioid epidemic, with callous disregard to the human suffering they caused,” Tong said in a statement. “The hundreds of millions of dollars they will now pay to states will go directly to abating this crisis but will never bring back those we have lost.”

Tong said he is continuing efforts to hold Stamford-based Purdue accountable for its role in the opioid crisis, although litigation is currently on hold during the company’s bankruptcy proceeding. 

Connecticut is also actively pursuing and investigating claims against pharmaceutical distributors who flooded states like Connecticut with powerfully addictive painkillers in amounts that they knew far exceeded legitimate prescriptions, Tong said.

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF